Cellevate is a startup based in Sweden, most recent round Series A, 2 tracked investors.
Based in Sweden, Cellevate is a startup founded in 2018. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
Cellevate develops nanofiber-based cell culture systems for biopharmaceutical applications, offering tools for cell and gene therapy production and vaccine manufacturing through proprietary Cellevat3d™ technology.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.